CONGRESS FOR VOTERS

DemocratBill · H.R. 6320· House(119-HR-6320)

Improving Medicaid Precision and Cancer Test Act of 2025

Rep. Gottheimer
Age: 51 years
New Jersey
Introduced
11/28/2025
Last activity
11/28/2025 — Referred to the House Committee on Energy and Commerce.
Sponsored by
Josh Gottheimer
Cosponsors
Democrat - 2Republican - 1
Health
  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the ``Improving Medicaid Precision and Cancer Test Act of 2025'', aims to amend title XIX of the Social Security Act. The primary goal is to require the Medicaid program to cover lung cancer biomarker testing. These changes involve amending specific sections of the Social Security Act, including sections 1902 and 1905. The coverage requirement is set to begin on January 1, 2027.

Yes· 3 of 9

  • Would households on low incomes be better off under this?+5

    The bill provides required coverage for lung cancer biomarker testing for Medicaid participants.

  • Does this put more money into Medicaid, the health coverage for people on low incomes?+5

    The bill mandates that Medicaid cover lung cancer biomarker testing starting January 1, 2027.

  • Does this make health care easier to get in general?+5

    The bill expands access to specialized lung cancer biomarker testing for Medicaid recipients.

The opposite

No question was scored the opposite.